I’m sure many of us are looking forward to wrapping up this tumultuous year for the markets sooner rather than later.

A recent bleak report identifies 3 drivers you should know about. But fear not because I have a silver lining to share with you.

Medical researchers are using what they know about our immune system and computers to make startling advances.

Deglobalization means many things, including opportunities for consultants and semiconductor design firms like these 2 stocks.

Deglobalization and energy transition will be a boon for the chip sector. Here’s how you can profit from this megatrend.

Inflation fears in 2022 have dominated the news cycle. But it is now clear that one American fast-food company has a fix.

The bullish narrative around decentralized finance is collapsing, and it is a big opportunity for legacy incumbents.

A personalized cancer vaccine could transform modern medicine, and investors need to know the companies behind it.

The Big Tech company seems unimpeded by the weakness in the global economy. It is selling every product it makes, and shares are still going down.

Investors needs to understand that huge new markets are taking shape, creating real winners. That’s why this stock is a buy for long-term investors.